Seeking Alpha


Send Message
View as an RSS Feed
View cnylax44's Comments BY TICKER:
Latest  |  Highest rated
  • Dynavax: Embarking On A Run Propelled By 2 Potential Approvals [View article]
    Did you miss the 80,000,000+ shares sold by the company at $1.07 (!!) over the last 60 days ???? You would have picked up this information if you merely reviewed the company news or their website. The balance of the article is a summary of previous articles posted.
    Dec 19 07:50 AM | 2 Likes Like |Link to Comment
  • AcelRx: Huge Potential With Limited Risk [View article]
    There are no sources other than previous Seeking Alpha articles which are summaries of underwriters research reports.
    Nov 27 07:34 PM | Likes Like |Link to Comment
  • The Biotech Merger And Acquisition Buzz List [View article]
    What do you attribute the major smackdown ACRX has seen over the last month ? Wow !
    Nov 6 11:05 AM | Likes Like |Link to Comment
  • Dendreon's Provenge: A Major Focus At The European Cancer Congress 2013 [View article]
    Still waiting to hear how DNDN is going to address their extremely dire balance sheet.
    Sep 17 09:36 AM | Likes Like |Link to Comment
  • Theravance Is Splitting Into Two Very Appealing Companies With Medium-Term Upside Of At Least 50% [View article]
    Please check your facts before publishing. On June 17, 2013 shareholders of Elan rejected the $1billion purchase of royalties from Theravance. This recommendation also goes to any editorial oversight as there are numerous factual errors in this article.
    Aug 30 02:56 PM | Likes Like |Link to Comment
  • Dynavax: Assembling The A-Team [View article]
    DVAX has been a disaster. I bet each one of these people wish they could have made another choice than to come to this sinking ship. Way too many issues behind the scenes that have gone on by the board of directors over the last few years.
    Jul 9 09:59 AM | 1 Like Like |Link to Comment
  • Dynavax: FDA Asks For Additional Safety Data [View article]
    What a disaster this company has been---including their management & certainly their board of directors.
    Jun 10 01:02 PM | 1 Like Like |Link to Comment
  • Trading Ahead Of The SAC Capital Fire Sale [View article]
    DVAX looks very interesting here.
    Jun 10 09:01 AM | Likes Like |Link to Comment
  • Jim Cramer Is Wrong About P&G [View article]
    Leave Cramer out of it. The guy professes to know almost every stock but needs to look at a chart book before making a comment. Many of his comments often are for "today only" and don't often have much impact outside of the TV trade. Watch his comments, for example, when he speaks on biotech----clearly someone is guiding him there. I agree that he's spread far too thin but he has a lot of fires in the iron.

    Bottom line you have to do your due diligence and decide what fits for you. Cramer has an opinion and style that seemingly works for him---do your best to find your own direction.
    Jun 4 08:40 AM | Likes Like |Link to Comment
  • Betting Splunk Goes Splat [View article]
    Any additional thoughts on SPLK from their conference call ?
    Jun 2 03:40 AM | Likes Like |Link to Comment
  • Trading Ahead Of The SAC Capital Fire Sale [View article]
    DVAX and DNDN both look like excellent plays.
    May 28 09:46 AM | Likes Like |Link to Comment
  • Cramer's Mad Money - The Difference Between Hewlett-Packard and ChannelAdvisor (5/23/13) [View article]
    Krammer on HPQ----don't touch it, I don't like it, don't buy it----LAST YEAR when it was a young teenager. I guess his chartbook told him to stay away. When a stock is weak on the charts stay away---when its strong buy buy buy.

    I guess when you rifle shot hundreds of stocks every week you need the chart book more than ever. The result----buyer beware of krammer if you don't realize this.
    May 24 04:40 PM | Likes Like |Link to Comment
  • Betting Splunk Goes Splat [View article]
    Since SPLK has had such a great move handily crushing the market averages on your great forecast-----should I consider taking some my significant gains off the table or let them run ? You are obviously much closer to the situation than I am & can probaly provide greater insight in the current environment.
    May 2 02:53 AM | Likes Like |Link to Comment
  • Vertex Spikes On Phase II Data, Then The CFO Sells His Shares [View article]
    Did you bother to check the expiration date on these options ? Were they close to their expiration date ? Are you remotely familiar with option terms in the compensation packages for company executives ?
    Apr 24 10:19 AM | Likes Like |Link to Comment
  • A Quick Response To Ariad's Conference Call [View article]
    ARIA stock was hit by one doctor who was an outlier. Also, fast money has swapped into other biotechs with better near-term profiles. ARIA doesn't have data coming for 5 more months in one indication & then 1st line CML data (the BIG key to the stock) is still 15+ months away. The launch is fine but moderate as its for salvage patients right now and there's only so many of them.
    I'm looking to accumulate shares again but with the understanding that ARIA will have a slower lift than the last run from $7-8/sh to $25/sh.
    Apr 5 12:39 PM | Likes Like |Link to Comment